Live Breaking News & Updates on Claus Egstrand|Page 7

Stay updated with breaking news from Claus egstrand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Enzymatica AB: Enzymatica publishes supplementary prospectus

LUND, Sweden, Aug. 18, 2022 /PRNewswire/ The Board of Directors of Enzymatica AB ("Enzymatica" or "Company") has issued a supplement (the "Supplementary Prospectus") in addition to the EU ....

United States , United Kingdom , Claus Egstrand , Stefan Olsson , University Of Innsbruck , Erik Penser Bank , Swedish Financial Supervisory Authority Finansinspektionen , Commission Delegated Directive , Financial Services , Swedish Financial Supervisory Authority , Supplementary Prospectus , Medical University , Rights Issue , Communication Manager , European Economic Area , South Africa , Markets Act , Financial Promotion , Prospectus Regulation , Member State , Governance Requirements , Target Market Assessment , Nasdaq First North Growth ,

Enzymatica publishes supplementary prospectus

/PRNewswire/ The Board of Directors of Enzymatica AB ("Enzymatica" or "Company") has issued a supplement (the "Supplementary Prospectus") in addition to the. ....

United States , United Kingdom , Claus Egstrand , Stefan Olsson , University Of Innsbruck , Erik Penser Bank , Swedish Financial Supervisory Authority Finansinspektionen , Commission Delegated Directive , Financial Services , Swedish Financial Supervisory Authority , Supplementary Prospectus , Medical University , Rights Issue , Communication Manager , European Economic Area , South Africa , Markets Act , Financial Promotion , Prospectus Regulation , Member State , Governance Requirements , Target Market Assessment , Nasdaq First North Growth , Enzymatica Ab , Medical Pharmaceuticals , Health Care Amp Hospitals ,

Enzymatica publishes supplementary prospectus (1)

Has issued a supplement (the "Supplementary Prospectus") in addition to the EU growth prospectus that has. ....

United States , United Kingdom , Claus Egstrand , Enzymatica Abphone , Stefan Olsson , University Of Innsbruck , Erik Penser Bank , Swedish Financial Supervisory Authority Finansinspektionen , Commission Delegated Directive , Financial Services , Swedish Financial Supervisory Authority , Supplementary Prospectus , Medical University , Rights Issue , Communication Manager , European Economic Area , South Africa , Markets Act , Financial Promotion , Prospectus Regulation , Member State , Governance Requirements , Target Market Assessment , Nasdaq First North Growth ,

Enzymatica publishes supplementary prospectus (2)

LUND, Sweden, Aug. 18, 2022 /PRNewswire/ The Board of Directors of Enzymatica AB ("Enzymatica" or. ....

United States , United Kingdom , Claus Egstrand , Enzymatica Abphone , Stefan Olsson , University Of Innsbruck , Erik Penser Bank , Swedish Financial Supervisory Authority Finansinspektionen , Commission Delegated Directive , Financial Services , Swedish Financial Supervisory Authority , Supplementary Prospectus , Medical University , Rights Issue , Communication Manager , European Economic Area , South Africa , Markets Act , Financial Promotion , Prospectus Regulation , Member State , Governance Requirements , Target Market Assessment , Nasdaq First North Growth ,

Publication of prospectus regarding Enzymatica's rights issue (1)

LUND, Sweden, Aug. 5, 2022 /PRNewswire/ The prospectus for Enzymatica AB's rights issue of around SEK. ....

United States , United Kingdom , Claus Egstrand , Enzymatica Abphone , Stefan Olsson , Setterwalls Advokatbyr , Erik Penser Bank , Swedish Financial Supervisory Authority Finansinspektionen , Commission Delegated Directive , Financial Services , Swedish Financial Supervisory Authority , Communication Manager , European Economic Area , South Africa , Markets Act , Financial Promotion , Prospectus Regulation , Member State , Governance Requirements , Target Market Assessment , Nasdaq First North Growth ,